PAX Financial Group’s Apellis Pharmaceuticals APLS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-9,591	Closed	-$874K	–	217
2023 Q2	$874K	Buy	9,591 +1,409	+17%	+$128K	0.2%	78
2023 Q1	$540K	Buy	+8,182	New	+$540K	0.13%	139